Literature DB >> 28527217

Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.

Joana Oliveira1, Márcio Costa1, Maria Soares Cachide de Almeida1, Odete A B da Cruz E Silva1, Ana Gabriela Henriques1.   

Abstract

Altered protein phosphorylation states of several proteins are closely associated with Alzheimer's disease (AD). Among these are the amyloid-β protein precursor (AβPP) and the tau protein. In fact, altered protein phosphorylation states already provide strong biomarkers for AD diagnosis, as is the case with hyperphosphorylated tau. It follows that modulating signaling cascades provides an attractive avenue for exploring novel therapeutic strategies. This review focuses on some of the major protein kinases and protein phosphatases relevant to AD. Of particular relevance, posttranslational modifications dynamically regulate protein activity, subcellular localization, and stability. Protein phosphorylation states can mediate complex formation as well as regulate protein function, and this is important for cellular physiology but can likewise contribute to the development of neuropathological conditions. Furthermore, applying a system approach provides a more comprehensive understanding of the signaling events associated with AD and highlights possible convergence points that may contribute to the different AD pathological hallmarks.

Entities:  

Keywords:  Alzheimer’s disease; AβPP binding proteins; amyloid cascade hypothesis; amyloid-β protein precursor; biomarkers; protein kinase; protein phosphatase; tau

Mesh:

Substances:

Year:  2017        PMID: 28527217     DOI: 10.3233/JAD-170176

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks.

Authors:  Hans-Ulrich Klein; Martin Schäfer; David A Bennett; Holger Schwender; Philip L De Jager
Journal:  PLoS Comput Biol       Date:  2020-04-07       Impact factor: 4.475

Review 2.  Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.

Authors:  Shon A Koren; Sara Galvis-Escobar; Jose F Abisambra
Journal:  Neurobiol Dis       Date:  2020-05-12       Impact factor: 5.996

Review 3.  Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects.

Authors:  Solomon Habtemariam
Journal:  Molecules       Date:  2018-01-07       Impact factor: 4.411

4.  Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.

Authors:  Benoît Melchior; Gopi Kumar Mittapalli; Carolyn Lai; Karen Duong-Polk; Joshua Stewart; Bora Güner; Brian Hofilena; Amanda Tjitro; Scott D Anderson; David S Herman; Luis Dellamary; Christopher J Swearingen; K C Sunil; Yusuf Yazici
Journal:  Aging Cell       Date:  2019-07-03       Impact factor: 9.304

Review 5.  Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease.

Authors:  Chao-Chao Yu; Tao Jiang; Ao-Fei Yang; Yan-Jun Du; Miao Wu; Li-Hong Kong
Journal:  Neural Plast       Date:  2019-04-10       Impact factor: 3.599

6.  GSKIP-Mediated Anchoring Increases Phosphorylation of Tau by PKA but Not by GSK3beta via cAMP/PKA/GSKIP/GSK3/Tau Axis Signaling in Cerebrospinal Fluid and iPS Cells in Alzheimer Disease.

Authors:  Huey-Jiun Ko; Shean-Jaw Chiou; Yu-Hui Wong; Yin-Hsuan Wang; YunLing Lai; Chia-Hua Chou; Chihuei Wang; Joon-Khim Loh; Ann-Shung Lieu; Jiin-Tsuey Cheng; Yu-Te Lin; Pei-Jung Lu; Ming-Ji Fann; Chi-Ying F Huang; Yi-Ren Hong
Journal:  J Clin Med       Date:  2019-10-21       Impact factor: 4.241

7.  G protein-coupled receptor kinases are associated with Alzheimer's disease pathology.

Authors:  Thais Rafael Guimarães; Eric Swanson; Julia Kofler; Amantha Thathiah
Journal:  Neuropathol Appl Neurobiol       Date:  2021-07-19       Impact factor: 8.090

Review 8.  The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer's Disease.

Authors:  Ian C Wood
Journal:  Front Neurosci       Date:  2018-09-19       Impact factor: 4.677

Review 9.  Phosphorylation Signaling in APP Processing in Alzheimer's Disease.

Authors:  Tao Zhang; Dongmei Chen; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2019-12-27       Impact factor: 5.923

10.  Association of Genes Involved in the Metabolic Pathways of Amyloid-β and Tau Proteins With Sporadic Late-Onset Alzheimer's Disease in the Southern Han Chinese Population.

Authors:  Xuewen Xiao; Bin Jiao; Xinxin Liao; Weiwei Zhang; Zhenhua Yuan; Lina Guo; Xin Wang; Lu Zhou; Xixi Liu; Xinxiang Yan; Beisha Tang; Lu Shen
Journal:  Front Aging Neurosci       Date:  2020-11-06       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.